Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy

Azahara Rodríguez-Domínguez, Margot Berings, Alexander Rohrbach, Huey-Jy Huang, Mirela Curin, Philippe Gevaert, Paolo M Matricardi, Rudolf Valenta, Susanne Vrtala

Research output: Journal article (peer-reviewed)Journal article

54 Citations (Scopus)


BACKGROUND: House dust mites (HDMs) are among the most important allergen sources containing many different allergenic molecules. Analysis of patients from a double-blind, placebo-controlled allergen-specific immunotherapy (AIT) study indicated that patients may benefit from AIT to different extents depending on their molecular sensitization profiles.

OBJECTIVE: Our aim was to investigate in a real-life setting whether stratification of patients with HDM allergy according to molecular analysis may enhance AIT success.

METHODS: Serum and nasal secretion samples from patients with HDM allergy (n = 24) (at baseline, 7, 15, 33, and 52 weeks) who had received 1 year of treatment with a well-defined subcutaneous AIT form (Alutard SQ 510) were tested for IgE and IgG reactivity to 15 microarrayed HDM allergen molecules with ImmunoCAP Immuno-solid-phase Allergen Chip technology. IgG subclass levels to allergens and peptides were determined by ELISA, and IgG blocking was assessed by basophil activation. In vitro parameters were related to reduction of symptoms determined by combined symptom medication score and visual analog scale score.

RESULTS: Alutard SQ 510 induced protective IgG mainly against Dermatophagoides pteronyssinus (Der p) 1 and Der p 2 and to a lesser extent to Der p 23, but not to the other important allergens such as Der p 5, Der p 7, and Der p 21, showing better clinical efficacy in patients sensitized only to Der p 1 and/or Der p 2 as compared with patients having additional IgE specificities.

CONCLUSION: Stratification of patients with HDM allergy according to molecular sensitization profiles and molecular monitoring of AIT-induced IgG responses may enhance the success of AIT.

Original languageEnglish
Pages (from-to)1097-1108
Number of pages12
JournalJournal of Allergy and Clinical Immunology
Issue number5
Publication statusPublished - Nov 2020


  • Adult
  • Animals
  • Antigens, Dermatophagoides/immunology
  • Arthropod Proteins/immunology
  • Cysteine Endopeptidases/immunology
  • Desensitization, Immunologic/methods
  • Epitopes/immunology
  • Female
  • Humans
  • Hypersensitivity/immunology
  • Immunoglobulin E/metabolism
  • Immunoglobulin G/metabolism
  • Injections, Subcutaneous
  • Male
  • Plant Extracts/therapeutic use
  • Protein Array Analysis
  • Pyroglyphidae


Dive into the research topics of 'Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy'. Together they form a unique fingerprint.

Cite this